Micalcl: A Potential Drug Target with Unique Features (G84953)

Target Name: MICALCL

NCBI ID: G84953

MICALCL

Micalcl: A Potential Drug Target with Unique Features

Micalcl (Ebitein-1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a member of the superfamily of cytoplasmic granules, which are a type of organelles that are found in eukaryotic cells. Micalcl is characterized by its unique structure, which consists of a long alpha-helices region that is derived from the N-terminus of the transmembrane protein ebitein-2 (EbI2).

One of the unique features of Micalcl is its ability to interact with various signaling molecules, including tyrosine and estrogen. This interaction allows Micalcl to play a role in the regulation of cellular processes that are critical for brain development, growth, and function.

Micalcl has also been shown to play a role in the regulation of cellular signaling pathways that are involved in inflammation, cell survival, and metabolism. For example, studies have shown that Micalcl can interact with the protein NG2 and that this interaction is involved in the regulation of cell proliferation and survival.

In addition to its role in cellular signaling, Micalcl has also been shown to have potential as a drug target. One of the reasons for this is the fact that Micalcl is a protein that is expressed in various tissues throughout the body, which makes it an attractive target for drug development. Additionally, the unique structure of Micalcl, which consists of a long alpha-helices region, makes it difficult to predict the specific binding sites on Micalcl that may be involved in drug interactions.

Despite the potential benefits of Micalcl as a drug target, there are also concerns about its potential side effects. For example, since Micalcl is expressed in various tissues throughout the body, it is possible that drugs that interact with Micalcl may have unintended consequences for other tissues. Additionally, since Micalcl is involved in the regulation of cellular processes that are critical for brain development, growth, and function, it is possible that drugs that interact with Micalcl may have negative effects on brain function.

In conclusion, Micalcl is a protein that is characterized by its unique structure and its ability to interact with various signaling molecules. Its potential as a drug target is due to its expression in various tissues throughout the body and its involvement in the regulation of cellular processes that are critical for brain development, growth, and function. However, there are also concerns about its potential side effects and the need for further research is needed to fully understand its potential as a drug.

Protein Name: MICAL C-terminal Like

The "MICALCL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MICALCL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets